Skip to main content
OpenTrials
Completed

NCT Number: NCT03222518

NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management

The purpose of this study is to:

Compare the effect of paracetamol alone against NSAIDs alone against the association of paracetamol + NSAIDs in the treatment of traumatic pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Monastir University Hospital

Monastir, 5000, Tunisia

About this study

Paracetamol, NSAIDs, or a combination of the two molecules are usually prescribed. Patients even use these medications without a prescription. It is not known, however, whether or not NSAIDs have an additional value relative to paracetamol for the treatment of pain.

All patients were assigned in a 1:1:1 ratio. Randomization of subjects was performed centrally according to a computer-generated random code provided by one of investigators who was not involved in any other part of the trial. The patients included were divided into 3 groups: Paracetamol group who received paracetamol 1000 mg orally every 8th hour for 7 days; NSAID group who received piroxicam 20 mg orally twice a day for 7 days, and Paracetamol-NSAID combination who received both treatments at the same doses for 7 days. All protocol treatments were administered in opaque packets with code number according to the randomization list by an independent nurse who was not involved in monitoring or follow-up of the individuals. Data were collected for each patient, including demographics, medical history, and findings of the clinical examination. Injury Severity Score (ISS) whose values range from 0 to 75 was also assessed. Each patient was re-evaluated on the 3rd and 7th day post-trauma (D7) using a telephone contact by a clinical research associates who was blinded to the details of the study to note the following clinical data: pain VNS, ED readmissions for residual pain, need for other analgesics other than those of the protocol, other treatment modalities the patient might have used (adherence to the treatment prescribed), and side effects. In addition patients were asked about their satisfaction with pain control following ED using five point Likert scale: very dissatisfied, not satisfied, neutral, satisfied and very satisfied and about the degree to which they adhered to medication schedule. The principal investigator who was aware of the allocation was not involved in monitoring or recording of the outcomes until the data collection was completed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18 years or older
  • acute (<24 hours) post traumatic pain of the extremity and requiring analgesic treatment upon discharge for pain with intensity >3 on a visual numeric scale

Exclusion criteria

  • open fracture
  • head, abdominal, thoracic or polytrauma.
  • Need for hospitalization, regular use of paracetamol and NSAIDs during the two weeks before admission to ED
  • history of allergy or hypersensitivity to either paracetamol or NSAIDs,
  • contraindication to paracetamol or NSAIDs,
  • acute /history of GI hemorrhage and renal insufficiency,
  • an inability to assess pain intensity according to the VNS.
  • Pregnancy
  • heart failure
  • known hepatic cirrhosis
  • known severe renal impairment (Creatinine clearance <30 ml/min)
  • swallowing disorders
  • Refusal, incapacity or difficulties to consent or to communicate

Treatment and study plan

Paracetamol

Drug

21 pills of Paracetamol 1000mg are provided with a preconised dose of 1 pill 3 times per day over 7 days period

NSAID

Drug

14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period

Other names: piroxicam

paracetamol-NSAID

Drug

21 identical pills of paracetamol ith a preconised dose of 1 pill 3 times per day over 7 days period+14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period

Other names: combination

Primary outcomes

  1. new oral analgesic medications needed rate

    Time frame: 3 days and 7 days

    oral analgesic medications other than those of the protocol prescribed by the treating physicians or taken by patients' own volition

Secondary outcomes

  1. the between-group difference in mean change in VNS score measured from ED discharge (VNS D0) to 7 days later

    Time frame: 3 and 7 days

    [delta VNS= (VNS D0 - VNS D7 / VNS D0) x 100]

  2. The appearance of side effects

    Time frame: 7 days

    The appearance of side effects: such as Drowsiness ,Decreased respiratory rate (<14 c / min), Cutaneous rash, Vomiting,Nausea,pruritus, Dizziness.

    • Digestive hemorrhage.
  3. the rate of ED readmissions for residual pain

    Time frame: 3 and 7 days

    ED readmissions for residual pain

  4. patient satisfaction assessed by Likert's verbal scale.

    Time frame: 3 and 7 days

    patient satisfaction assessed by Likert's verbal scale.

Sponsors and collaborators

Lead sponsor

University of Monastir

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jul 19, 2017
Registry last updated
Sep 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.